dr. T.J.N. Hiltermann

Faculty of Medical Sciences

Telephone:

E-mail:

t.j.n.hiltermann umcg.nl

ORCID Research Portal

Publications

128P - Whole blood transcriptomics identifies transcriptional patterns linked to outcomes in patients receiving immune checkpoint inhibitors

Hone Lopez, S., Loipfinger, S., Bhattacharya, A., Jalving, M., Oosting, S. F., Hiltermann, J., de Bruyn, M., de Vries, E. G. E., de Haan, J.-J. & Fehrmann, R., 14-Sept-2024, In: Annals of Oncology. 35, Supplement 2, p. S266 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Baseline Blood CD8+ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer

Kievit, H., Muntinghe-Wagenaar, M. B., Abdulahad, W. H., Rutgers, A., Hijmering-Kappelle, L. B. M., Hiddinga, B. I., Ubbels, J. F., Wijsman, R., van der Leij, M. J., Bijzet, J., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J., Kroesen, B.-J. & Hiltermann, T. J. N., 19-Jul-2024, In: Cancers. 16, 14, 12 p., 2592.

Research output: Contribution to journal › Article › Academic › peer-review

Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer

Muller, M., Best, M. G., van der Noort, V., Hiltermann, T. J. N., Niemeijer, A.-L. N., Post, E., Sol, N., In 't Veld, S. G. J. G., Nogarede, T., Visser, L., Schouten, R. D., van den Broek, D., Hummelink, K., Monkhorst, K., de Langen, A. J., Schuuring, E., Smit, E. F., Groen, H. J. M., Wurdinger, T. & van den Heuvel, M. M., 19-Mar-2024, In: Tumor Biology. 46, 1, p. S327-S340 14 p.

Research output: Contribution to journal › Article › Academic › peer-review

BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study

Kalinka, E., Bahce, I., Navarro Mendivil, A. F., Ready, N., Chu, Q.-C., Sugawara, S., Sibille, A., Provencio Pulla, M., Johnson, M. L., Hiltermann, J. T. J. N., Ciuleanu, T.-E., Dziadziuszko, R., Santo, A., Zhang, Y., Liu, Y., Sarmiento, R., Tannenbaum-Dvir, S., Ojalvo, L., Wu, J. & O’Byrne, K. J., Sept-2024, In: Annals of Oncology. 35, Supplement 2, p. S1061-S1062 2 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Clinical outcomes with perioperative nivolumab (NIVO) by nodal status among patients (pts) with stage III resectable NSCLC: Results from the phase 3 CheckMate 77T study

Provencio, M., Awad, M. M., Spicer, J., Janssens, A., Moiseenko, F. V., Gao, Y., Watanabe, Y., Alexandru, A., Guisier, F., Frost, N., Franke, F. A., Hiltermann, T. J. N., He, J., Tanaka, F., Lu, S., Erdmann, C. C., Sathyanarayana, P., Tran, P., Devas, V. & Cascone, T., 5-Jun-2024, In: Journal of Clinical Oncology. 42, 17_suppl, LBA8007.

Research output: Contribution to journal › Meeting Abstract › Academic

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Vermeulen, O. C. B., Brouwer, E., Slart, R. H. J. A., Sandovici, M., Rutgers, A., Hilterman, T. J., Hiddinga, B., Oosting, S. F., Jalving, M., de Heij, A. H., Knapen, D. G., Hospers, G. A. P. & van der Geest, K. S. M., 9-Feb-2024, (E-pub ahead of print) In: Rheumatology (Oxford, England). 9 p., keae099.

Research output: Contribution to journal › Erratum

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

de Jager, V. D., Plomp, P., Paats, M. S., van Helvert, S., Elst, A. T., van den Berg, A., Dubbink, H. J., van Geffen, W. H., Zhang, L., Hendriks, L. E. L., Hiltermann, T. J. N., Hiddinga, B. I., Hijmering-Kappelle, L. B. M., Jalving, M., Kluiver, J., Koopman, B., van Kruchten, M., van der Logt, E. M. J., Piet, B. & van Putten, J.& 10 others, Reitsma, B. H., Rutgers, S. R., de Vries, M., Stigt, J. A., Groves, M. R., Timens, W., Willems, S. M., van Kempen, L. C., Schuuring, E. & van der Wekken, A. J., Nov-2024, In: ESMO Open. 9, 11, 12 p., 103966.

Research output: Contribution to journal › Article › Academic › peer-review

mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy

Gangaev, A., van Sleen, Y., Brandhorst, N., Hoefakker, K., Prajapati, B., Singh, A., Boerma, A., van der Heiden, M., Oosting, S. F., van der Veldt, A. A. M., Hiltermann, T. J. N., GeurtsvanKessel, C. H., Dingemans, A.-M. C., Smit, E. F., de Vries, E. G. E., Haanen, J. B. A. G., Kvistborg, P. & van Baarle, D., Aug-2024, In: Frontiers in Immunology. 15, 13 p., 1447555.

Research output: Contribution to journal › Article › Academic › peer-review

Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report

de Jager, V. D., van Kempen, L. C., Cajiao Garcia, B. N., Hiltermann, T. J. N., van der Wekken, A. J., Schuuring, E. & Willems, S. M., Dec-2024, In: JTO clinical and research reports. 5, 12, 6 p., 100745.

Research output: Contribution to journal › Article › Academic › peer-review

The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors

Horstman, I. M., Vinke, P. C., Suazo-Zepeda, E., Hiltermann, T. J. N., Heuvelmans, M. A., Corpeleijn, E. & de Bock, G. H., Aug-2024, In: Thoracic Cancer. 15, 23, p. 1764-1771 8 p.

Research output: Contribution to journal › Article › Academic › peer-review